Comparison of permethrin 2.5 % cream vs. Tenutex emulsion for the treatment of scabies

• Autorzy: Goldust M. , Rozaee E. , Raghifar R. , Naghavi-Behzad M.
• Języki publikacji: EN

Abstrakty

EN

Scabies is a common parasitic infestation that is an important public-health problem in many resourcepoor regions. It is commonly treated with the insecticides but the treatment of choice is still controversial. This study aimed at comparing the efficacy of permethrin 2.5% cream vs. Tenutex emulsion for the treatment of scabies. In total, 440 patients with scabies were enrolled, and randomized into two groups The first group received permethrin 2.5% cream twice with one week interval and the second group received Tenutex emulsion and were told to apply this once whole-body application. Treatment was evaluated at intervals of 2 and 4 weeks, and if there was treatment failure at the 2-week follow-up, treatment was repeated.Two application of permethrin 2.5% cream provided a cure rate of 63.6% at the 2-week follow-up, which increased to 86.3% at the 4-week follow-up after repeating the treatment. Treatment with single applications of Tenutex emulsion was effective in 45.4% of patients at the 2-week follow-up, which increased to 59.1% at the 4-week follow-up after this treatment was repeated.Two application of permethrin 2.5% cream was as effective as single applications of Tenutex emulsion at the 2-week follow-up. After repeating the treatment, permethrin 2.5% cream was superior to Tenutex emulsion at the 4-week follow up.

Słowa kluczowe

EN

comparison; permethrin; cream; Tenutex emulsion; treatment; scabies; parasitic disease; skin disease

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2013
• Tom: 59
• Numer: 1
• Opis fizyczny: p.31-35,ref.

Twórcy

autor

Goldust M.

• Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

autor

Rozaee E.

• Department of Medicinal Chemistry, Shahid Beheshti University of Medical Sciences, Teheran, Iran

autor

Raghifar R.

• Tabriz Azad University of Medical Sciences, Tabriz, Iran

autor

Naghavi-Behzad M.

• Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Bibliografia

• [1] Goldust M., Golforoushan F., Ranjkesh M.R., Babae N.S., Rezaee E. 2012. Comparative trial of Permethrin 5% vs. Lindane 1 % for the treatment of scabies. Journal of Dermatological Treatment. doi: 10.3109/09546634.2012.723122.
• [2] Fernandez-Sanchez M., Saeb-Lima M., Alvarado-de la Barrera C., Reyes-Teran G. 2012. Crusted scabiesassociated immune reconstitution inflammatory syndrome. BMC Infectious Diseases 12: 323.
• [3] Talukder K., Talukder M.Q., Farooque M.G., Khairul M., Sharmin F., Jerin I., Rahman M.A. 2012. Controlling scabies in madrasahs (Islamic religious schools) in Bangladesh. Public Health 127: 83-91.
• [4] Gunning K., Pippitt K., Kiraly B., Sayler M. 2012. Pediculosis and scabies: treatment update. American Family Physician 86: 535-541.
• [5] Gaspard L., Laffitte E., Michaud M., Eicher N., Lacour O., Toutous-Trellu L. 2012. Scabies in 2012. Revue Medicale Suisse 8: 718-725 (In French).
• [6] Lavery M.J., Parish L.C., Wolf R. 2012. Scabies then and now. Skinmed 10: 67-69.
• [7] Goldust M., Ranjkesh M.R., Amirinia M., Golforoushan F., Rezaee E., Rezazadeh-Saatiou M.A. 2012. Sertaconazole 2 % cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis. Journal of Dermatological Treatment. doi: 10.3109/09546634.2012.755251.
• [8] Lopatina I. 2012. Resistance of the itch mites Sarcoptes scabiei De Geer, 1778 to scabicides. Meditsinskaia Parazitologiia: 49-54 (In Russian).
• [9] Goldust M., Rezaee E., Hemayat S. 2012. Treatment of scabies: Comparison of permethrin 5% versus ivermectin. Journal of Dermatology 39: 545-547.
• [10] Stoevesandt J., Carle L., Leverkus M., Hamm H. 2012. Control of large institutional scabies outbreaks. Journal der Deutschen Dermatologischen Gesellschaft 10: 637-647.
• [11] Monsel G., Chosidow O. 2012. Management of scabies. Skin Therapy Letter 17: 1-4.
• [12] Wang C.H., Lee S.C., Huang S.S., Kao Y.Y., See L.C., Yang S.H. 2012. Risk factors for scabies in Taiwan. Journal of Microbiology, Immunology and Infection 45: 276-280.
• [13] Hay R.J., Steer A.C., Engelman D., Walton S. 2012. Scabies in the developing world – its prevalence, complications, and management. Clinical Microbiology and Infection 18: 313-323.
• [14] Currier R.W., Walton S.F., Currie B.J. 2011. Scabies in animals and humans: history, evolutionary perspectives, and modern clinical management. Annals of NY Academy of Sciences 1230: E50-E60.
• [15] Sharquie K.E., Al-Rawi J.R., Noaimi A.A., Al-Hassany H.M. 2012. Treatment of scabies using 8% and 10% topical sulfur ointment in different regimens of application. Journal of Drugs in Dermatology 11: 357-364.
• [16] Chosidow O. 2012. Scabies and pediculosis: neglected diseases to highlight. Clinical Microbiology and Infection 18: 311-312.
• [17] Worth C., Heukelbach J., Fengler G., Walter B., Liesenfeld O., Hengge U., Feldmeier H. 2012. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatric Dermatology 29: 430-436.
• [18] Gould D. 2010. Prevention, control and treatment of scabies. Nursing Standard 25: 42-46.
• [19] Bachewar N.P., Thawani V.R., Mali S.N., Gharpure K.J., Shingade V.P., Dakhale G.N. 2009. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian Journal of Pharmacology 41: 9-14.
• [20] Modamio P., Lastra C.F., Sebarroja J., Marino E.I. 2009. Stability of 5% permethrin cream used for scabies treatment. Pediatric Infectious Disease Journal 28: 668.
• [21] Pasay C., Arlian L., Morgan M., Vyszenski-Moher D., Rose A., Holt D., Walton S., McCarthy J. 2008. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Medical and Veterinary Entomology 22: 82-88.
• [22] Abedin S., Narang M., Gandhi V., Narang S. 2007. Efficacy of permethrin cream and oral ivermectin in treatment of scabies. Indian Journal of Pediatrics 74: 915-916.
• [23] Kolmodin-Hedman B., Borglund E., Werner Y. 1979. Percutaneous absorption of DDT from a parasiticide used for treatment of scabies. Acta Dermato-Venereologica 59: 276-278.
• [24] Brinck-Lindroth G., Lundqvist L., Nilsson A. 1984. Control of the human head louse with disulfiram and benzyl benzoate emulsions. A laboratory study. Acta Dermato-Venereologica 64: 325-330.
• [25] Ayoub N., Merhy M., Tomb R. 2009. Treatment of scabies with albendazole. Dermatology 218: 175.
• [26] Naeher L.P., Barr D.B., Rithmire N., Edwards J., Holmes A.K., Needham L.L., Rubin C.S. 2009. Pesticide exposure resulting from treatment of lice infestation in school-aged children in Georgia. Environment International 35: 358-362.
• [27] Mumcuoglu K.Y., Gilead L. 2008. Treatment of scabies infestations. Parasite 15: 248-251.
• [28] Ishii N. 2008. Guideline for the diagnosis and treatment of scabies in Japan (second edition). Journal of Dermatology 35: 378-393.
• [29] Elgart M.L. 2003. Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabies. Expert Opinion on Pharmacotherapy 4:1521-1524.
• [30] Amerio P., Capizzi R., Milani M. 2003. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigatorblinded, comparative trial vs. permethrin cream. European Journal of Dermatology 13: 69-71.
• [31] Paasch U., Haustein U.F. 2001. Treatment of endemic scabies with allethrin, permethrin and ivermectin. Evaluation of a treatment strategy. Hautarzt 52: 31-37 (In Deutsch).
• [32] Paasch U., Haustein U.F. 2000. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. International Journal of Dermatology 39: 463-470.
• [33] Landegren J., Borglund E., Storgards K. 1979. Treatment of scabies with disulfiram and benzyl benzoate emulsion: a controlled study. Acta Dermato-Venereologica 59: 274-276.
• [34] Permethrin Nursing Times 2005, 101: 29.
• [35] Tomalik-Scharte D., Lazar A., Meins J., Bastian B., Ihrig M., Wachall B., Jetter A., Tantcheva- Poor I., Mahrle G., Fuhr U. 2005. Dermal absorption of permethrin following topical administration. European Journal of Clinical Pharmacology 61: 399-404.
• [36] Haustein U.F. 2006. Treatment of scabies. Permethrin is the remedy of choice. Journal der Deutschen Dermatologischen Gesellschaft 4: 387-390 (In Deutsch).
• [37] Zargari O., Golchai J., Sobhani A., Dehpour A.R., Sadr-Ashkevari S., Alizadeh N., Darjani A. 2006. Comparison of the efficacy of topical 1% lindane vs 5% permethrin in scabies: a randomized, double-blind study. Indian Journal of Dermatology, Venereology and Leprology 72: 33-36.
• [38] Usha V., Gopalakrishnan Nair T.V. 2000. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology 42: 236-240.
• [39] Mytton O.T., McGready R., Lee S.J., Roberts C.H., Ashley E.A., Carrara V.I., Thwai K.L., Jay M.P., Wiangambun T., Singhasivanon P., Nosten F. 2007. Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG 114: 582-587.